Pyng enhanced infusion system
This article was originally published in Clinica
Executive Summary
The US FDA has awarded special 510(k) clearance to Canadian firm Pyng Medical, allowing the sale of an improved version of the FAST1 intraosseous infusion system. Vancouver-based Pyng claims that the device is the most rapid, reliable and safe alternative to IV infusion, and provides lifesaving vascular access for fluid and drug resuscitation in shock and trauma victims. The improved system has an infusion tube that no longer requires the use of a removal tool; Pyng said that the improvements reflect feedback from key customers based on real-life applications in the battlefield and emergency environments. The product will be launched in the US immediately.